Çó¹ºÐÅÏ¢ | ¹©Ó¦ÐÅÏ¢ | ¹«Ë¾µ¼º½ | ÉÌÎñÂÛ̳ | °Ë·½Í¨ | °ïÖú

¹©Ó¦ÐÅÏ¢×ÜÊý£º6675044Ìõ    ×îй©Ó¦ÐÅÏ¢£º0Ìõ

 
·ÖÀàĿ¼ => ¹©Ó¦ÐÅÏ¢·ÖÀà => »¯¹¤
Ïà¹ØÄ¿Â¼: ¹©ÇóĿ¼ => ¹©Ó¦Ä¿Â¼ => »¯¹¤
¡¡
  ¹©Ó¦ÉÌ»úÀà±ð
»úе¼°¹¤ÒµÖÆÆ·(833185)
»¯¹¤(576402)
¼Ò¾ÓÓÃÆ·(127632)
µç×ӵ繤(521880)
»·±£(97680)
·ÄÖ¯¡¢Æ¤¸ï(92920)
½¨Öþ¡¢½¨²Ä(330955)
·þ×°¡¢Ð¬Ã±(93311)
µçÄÔÓëÈí¼þ(146406)
ũҵ(152013)
ʳƷ¡¢ÒûÁÏ(103531)
°ü×°¡¢Ö½(170665)
ÉÌÎñ·þÎñ(216080)
Ò±½ð¿ó²ú(309258)
°ì¹«¡¢ÎĽÌ(101056)
¼ÒÓõçÆ÷(129860)
ÆûĦ¼°Åä¼þ(97615)
Ô˶¯¡¢ÐÝÏÐ(74272)
ͨѶ²úÆ·(67456)
°²È«¡¢·À»¤(165703)
ÄÜÔ´(90793)
Íæ¾ß(40892)
¼Ó¹¤(59121)
Ó¡Ë¢¡¢³ö°æ(62031)
½»Í¨ÔËÊä(92837)
´úÀí(73762)
ÀñÆ·¡¢¹¤ÒÕÆ·¡¢ÊÎÆ·(190599)
×ÛºÏÐÔ¹©Ó¦ÉÌ»ú(66169)
Ö½Òµ(14554)
´«Ã½(41279)
·þÊÎ(72014)
ÏðËÜ(178683)
¾«Ï¸»¯Ñ§Æ·(101090)
µç×ÓÔªÆ÷¼þ(196162)
ÕÕÃ÷¹¤Òµ(76571)
Îå½ð¡¢¹¤¾ß(342554)
ÒÇÆ÷ÒDZí(270942)

¡¡

¡¡

¡¡

¡¡

¡¡

¡¡

¡¡

¡¡

¡¡

  »¯¹¤ 

Ò³´Î£º47088/54516Ò³  ÏÔʾ100ÌõÐÅÏ¢/Ò³   93 47088 47089 47090 47091 47092 47093 47094 47095 47096 47097 4 :

¹©Ó¦½âëåëåÔ­Ì忹Ìå(UU-Ab)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼×°·à©ßÊ(MTX)ÊÔ¼ÁºÐ ¼îÐÔÁ×Ëáø(ALP)ÊÔ¼ÁºÐ Na+/H+½»»»Ìå3(NHE3)ÊÔ¼ÁºÐ ½ºÔ­C ¶ËëÄø(PCP)ÊÔ¼ÁºÐ ½âëåëåÔ­Ì忹Ìå(UU-Ab)ÊÔ¼ÁºÐ ¾«°±Ëá¼ÓÑ¹ËØ(AVP)ÊÔ¼ÁºÐ

¹©Ó¦¼×ÖÖÌ¥¶ùÇòµ°°×/¼×Ì¥µ°°×(AFP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼×ÖÖÌ¥¶ùÇòµ°°×/¼×Ì¥µ°°×(AFP)ÊÔ¼ÁºÐ

¹©Ó¦½µ¸ÆËØ(CT)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
½µ¸ÆËØ(CT)ÊÔ¼ÁºÐ

¹©Ó¦½Þ×´Éñ¾­ÓªÑøÒò×Ó(CNTF)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
½Þ×´Éñ¾­ÓªÑøÒò×Ó(CNTF)ÊÔ¼ÁºÐ

¹©Ó¦¹ÇÐÎ̬·¢Éúµ°°×(BMPs)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¹ÇÐÎ̬·¢Éúµ°°×(BMPs)ÊÔ¼ÁºÐ ¹ÇÐγɵ°°×6(BMP-6)ÊÔ¼ÁºÐ ¹Ç±£»¤ËØ(OPG)ÊÔ¼ÁºÐ ¹Ç±£»¤ËØÅäÌå(OPGL)ÊÔ¼ÁºÐ ¹Ç¸ÆËØ/¹Ç¹È°±Ëáµ°°×(OT/BGP)ÊÔ¼ÁºÐ ¹ÇÇÅËØ(OPN)ÊÔ¼

¹©Ó¦¦Á1 ËáÐÔÌǵ°°×(¦Á1-AGP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¦Á1 ËáÐÔÌǵ°°×(¦Á1-AGP)ÊÔ¼ÁºÐ ˮͨµÀµ°°×5(AQP-5)ÊÔ¼ÁºÐ ˮͨµÀµ°°×4(AQP-4)ÊÔ¼ÁºÐ ˮͨµÀµ°°×3(AQP-3)ÊÔ¼ÁºÐ ˮͨµÀµ°°×1(AQP-1)ÊÔ¼ÁºÐ ˮͨµÀµ°°×0(AQP

¹©Ó¦¹È°±ËáÍÑôÈø×ÔÉí¿¹Ìå(GAD-Ab)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¸ßÁéÃô¶È´Ù¼××´ÏÙ¼¤ËØ(U-TSH)ÊÔ¼ÁºÐ ¹È°±ËáÍÑôÈø×ÔÉí¿¹Ìå(GAD-Ab)ÊÔ¼ÁºÐ ¼×ë¿Ç°ÁÐÏÙËØD2(PGD2-MOX)ÊÔ¼ÁºÐ ¼××´Ïٴ̼¤¼¤ËØ(TSI)ÊÔ¼ÁºÐ ¼××´ÅÔÏÙ¼¤ËØ(PTH)ÊÔ¼

¹©Ó¦ÊÜÌåÀÒ°±Ëἤø(RTKs)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ë®òÎËØ(Hirudin)ÊÔ¼ÁºÐ ÊÜÌåÀÒ°±Ëἤø(RTKs)ÊÔ¼ÁºÐ ÉöÒÆÖ²Ëû¿ËĪ˾(FK506)ÊÔ¼ÁºÐ ÉöСÇò×éÖ¯ÌÇ»ù»¯ÖÕÄ©²úÎï(GTE-AGE)ÊÔ¼ÁºÐ Éñ¾­½µÑ¹ËØ(NT)ÊÔ¼ÁºÐ Ë¿ÁÑÔ­¼

¹©Ó¦É±ÉËϸ°ûÃâÒßÇòµ°°×ÑùÊÜÌå(KIR)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ɱÉËϸ°ûÃâÒßÇòµ°°×ÑùÊÜÌå(KIR)ÊÔ¼ÁºÐ ɱÉËϸ°ûÄý¼¯ËØÑùÊÜÌå(KLR)ÊÔ¼ÁºÐ Éú³¤Ïà¹Øµ°°×43(GAP-43)ÊÔ¼ÁºÐ Éú³¤¼¤ËؽáºÏµ°°×(GHBP)ÊÔ¼ÁºÐ Êȸõµ°°×A(CgA)ÊÔ¼ÁºÐ

¹©Ó¦¿¹Í¸Ã÷´ø¿¹Ìå(aZP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹Í¸Ã÷´ø¿¹Ìå(aZP)ÊÔ¼ÁºÐ ¿¹Âѳ²¿¹Ìå(AOAb)ÊÔ¼ÁºÐ ¿¹×Ó¹¬ÄÚĤ¿¹Ìå(EM-Ab)ÊÔ¼ÁºÐ ¿¹¾«×Ó¿¹Ìå(AsAb)ÊÔ¼ÁºÐ ÈÑÉïÌØÒìÐÔ¦Â1 Ìǵ°°×(SP1/PS¦Â1-G)ÊÔ¼ÁºÐ ÈÑÉïÏà¹

¹©Ó¦´Ù¼××´ÏÙËØÊͷż¤ËØ(TRH)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
´ÙÉöÉÏÏÙÆ¤Öʼ¤ËØ(ACTH)ÊÔ¼ÁºÐ ´Ù¼××´ÏÙËØÊͷż¤ËØ(TRH)ÊÔ¼ÁºÐ ´ÙÉöÉÏÆ¤Öʼ¤ËØÊͷż¤ËØ(CRH)ÊÔ¼ÁºÐ ´ÙÐÔÏÙ¼¤ËØÊͷż¤ËØ(GnRH)ÊÔ¼ÁºÐ ´ÙÂÑÅÝËØ(FSH)ÊÔ¼ÁºÐ ´

¹©Ó¦·ÎÑ×Ö§Ô­Ì忹Ìå(MP Ab)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
·ÎÑ×Ö§Ô­Ì忹Ìå(MP Ab)ÊÔ¼ÁºÐ ¿¹ÈËÀàÃâÒßȱÏݲ¡¶¾¿¹Ìå(HIV)ÊÔ¼ÁºÐ ÈéÍ·×´Áö²¡¶¾¿¹Ìå(HPV)ÊÔ¼ÁºÐ ÈéÍ·×´Áö²¡¶¾¿¹ÌåIgM(HPV-IgM)ÊÔ¼ÁºÐ ÈéÍ·×´Áö²¡¶¾¿¹ÌåIgG(H

¹©Ó¦×ãϸ°û±ê¼Çµ°°×(PCX)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
×ãϸ°û±ê¼Çµ°°×(PCX)ÊÔ¼ÁºÐ ×é°·(HIS)ÊÔ¼ÁºÐ ÈËÌØÖÖµ°°×ϵÁмì²âELISA ÊÔ¼ÁºÐ[Human Special Protein ELISA Kit] °¢À­²®°ëÈéÌǵ°°×(AGPs)ÊÔ¼ÁºÐ °×ϸ°ûµ

¹©Ó¦µ¥´¿ðåÕ¶¾¢ñÐÍ¿¹Ìå(HSV¢ñ-Ab)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
µ¥´¿ðåÕ¶¾¢ñÐÍ¿¹Ìå(HSV¢ñ-Ab)ÊÔ¼ÁºÐ µ¥´¿ðåÕ¶¾¿¹Ô­2(HSV-Ag2)ÊÔ¼ÁºÐ µ¥´¿ðåÕ¶¾¿¹Ô­-1(HSV-Ag1)ÊÔ¼ÁºÐ ·ÎÑ×Ö§Ô­Ì忹Ìå(MP Ab)ÊÔ¼ÁºÐ ¿¹ÈËÀàÃâÒßȱÏÝ

¹©Ó¦ÈÑÉïÌØÒìÐÔ¦Â1 Ìǵ°°×(SP1/PS¦Â1-G)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÈÑÉïÌØÒìÐÔ¦Â1 Ìǵ°°×(SP1/PS¦Â1-G)ÊÔ¼ÁºÐ ÈÑÉïÏà¹ØÑª½¬µ°°×A(PAPP-A)ÊÔ¼ÁºÐ Ì¥Å̺ËÌǺËËáÒÖÖ¹¼Á(HPRI)ÊÔ¼ÁºÐ Ì¥Å̼îÐÔÁ×Ëáø(PLAP)ÊÔ¼ÁºÐ Ì¥Å̵°°×(PP)ÊÔ¼Á

¹©Ó¦Ì¥Å̼îÐÔÁ×Ëáø(PLAP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ì¥Å̼îÐÔÁ×Ëáø(PLAP)ÊÔ¼ÁºÐ Ì¥Å̵°°×(PP)ÊÔ¼ÁºÐ Ì¥ÅÌ´ßÈéËØ(HPL)ÊÔ¼ÁºÐ Ì¥ÅÌÃÚÈéËØ(PL)ÊÔ¼ÁºÐ ÔÐͪÊÜÌå(PGR)ÊÔ¼ÁºÐ ÐÂÉú¶ù´Ù¼××´ÏÙËØ(N-TSH)ÊÔ¼ÁºÐ ÐÛ¼¤Ë

¹©Ó¦×éÖ¯µ°°×øD(cath-D)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
×éÖ¯µ°°×øD(cath-D)ÊÔ¼ÁºÐ CCAAT ÔöÇ¿×Ó½áºÏµ°°×¦Å(C/EBP¦Å)ÊÔ¼ÁºÐ CCAAT ÔöÇ¿×Ó½áºÏµ°°×¦Ä(C/EBP¦Ä)ÊÔ¼ÁºÐ CCAAT ÔöÇ¿×Ó½áºÏµ°°×¦Â(C/EBP¦Â)ÊÔ¼ÁºÐ CCAAT

¹©Ó¦´Æ¶þ´¼ÊÜÌå(ER)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
´Æ¶þ´¼ÊÜÌå(ER)ÊÔ¼ÁºÐ ´ÆÈý´¼(E3)ÊÔ¼ÁºÐ ´Æ¼¤ËØ(E)ÊÔ¼ÁºÐ ´Æ¼¤ËØÊÜÌå(ER)ÊÔ¼ÁºÐ ´ÙÉú³¤¼¤ËØÊͷż¤ËØ(GRH)ÊÔ¼ÁºÐ ´ÙÉöÉÏÏÙÆ¤Öʼ¤ËØ(ACTH)ÊÔ¼ÁºÐ ´Ù¼××´ÏÙËØ

¹©Ó¦¿¹ÈËÀàÃâÒßȱÏݲ¡¶¾¿¹Ìå(HIV)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹ÈËÀàÃâÒßȱÏݲ¡¶¾¿¹Ìå(HIV)ÊÔ¼ÁºÐ ÈéÍ·×´Áö²¡¶¾¿¹Ìå(HPV)ÊÔ¼ÁºÐ ÈéÍ·×´Áö²¡¶¾¿¹ÌåIgM(HPV-IgM)ÊÔ¼ÁºÐ ÈéÍ·×´Áö²¡¶¾¿¹ÌåIgG(HPV-IgG)ÊÔ¼ÁºÐ ɳÑÛÒÂÔ­Ì忹Ìå

¹©Ó¦ÍíÆÚÑõ»¯µ°°×²úÎï(AOPP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÍíÆÚÑõ»¯µ°°×²úÎï(AOPP)ÊÔ¼ÁºÐ ÍøÓ²µ°°×(Reticulin)ÊÔ¼ÁºÐ θÃÚËØÊÍ·ÅëÄǰÌå(ProGRP)ÊÔ¼ÁºÐ θÃÚËØÊͷŶàëÄ(GRP)ÊÔ¼ÁºÐ δÁ×ËữÀàÒȵºËØÉú³¤Òò×Ó½áºÏµ°°×-1

¹©Ó¦ÍÑÑõ½ºÔ­ßÁऽ»Áª(DPD)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÍÑÑõ½ºÔ­ßÁऽ»Áª(DPD)ÊÔ¼ÁºÐ ÍíÆÚÑõ»¯µ°°×²úÎï(AOPP)ÊÔ¼ÁºÐ ÍøÓ²µ°°×(Reticulin)ÊÔ¼ÁºÐ θÃÚËØÊÍ·ÅëÄǰÌå(ProGRP)ÊÔ¼ÁºÐ θÃÚËØÊͷŶàëÄ(GRP)ÊÔ¼ÁºÐ δÁ×Ë

¹©Ó¦ÓÎÀë´ÆÈý´¼(FE3)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÒȵºËØ×ÔÉí¿¹Ìå(IAA)ÊÔ¼ÁºÐ Toll ÑùÊÜÌå9(TLR-9)ÊÔ¼ÁºÐ ÓÎÀë´ÆÈý´¼(FE3)ÊÔ¼ÁºÐ ÓÎÀë¦ÂÈÞëĤ´ÙÐÔÏÙ¼¤ËØ(f-¦ÂhCG)ÊÔ¼ÁºÐ ×ãϸ°û±ê¼Çµ°°×(PCX)ÊÔ¼ÁºÐ ×é°·(HI

¹©Ó¦Î¢¹ÜÏà¹Øµ°°×2(MAP-2)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
΢¹ÜÏà¹Øµ°°×2(MAP-2)ÊÔ¼ÁºÐ ÏËάµ°°×Ô­(Fg)ÊÔ¼ÁºÐ ÏËάµ°°×ëÄB(FPB)ÊÔ¼ÁºÐ ÏËάµ°°×(Fbn)ÊÔ¼ÁºÐ ÏËάµ°°×ëÄA(FPA)ÊÔ¼ÁºÐ Ï˵÷µ°°×(fibromodulin)ÊÔ¼ÁºÐϸ

¹©Ó¦ÌÇ»¯Ñªºìµ°°×/ÌÇÄò²¡ÌÇ»¯Ñªºìµ°°×(GHB)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÌÇ»¯Ñªºìµ°°×/ÌÇÄò²¡ÌÇ»¯Ñªºìµ°°×(GHB)ÊÔ¼ÁºÐ ÌÇ»¯µ°°×(GSP)ÊÔ¼ÁºÐ ÌÇ»¯°×µ°°×(GA)ÊÔ¼ÁºÐ TH Ìǵ°°×(THP)ÊÔ¼ÁºÐ ̼Ëáôûø2(CA-2)ÊÔ¼ÁºÐ Í­À¶µ°°×(CP/CER)ÊÔ

¹©Ó¦ÐÄÐÍÖ¬·¾Ëá½áºÏµ°°×(h-FABP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÐÄÐÍÖ¬·¾Ëá½áºÏµ°°×(h-FABP)ÊÔ¼ÁºÐ ÏÙÜÕÈýÁ×Ëá½áºÏºÐתÔËÌåA1(ABCA1)ÊÔ¼ÁºÐ ѪÇå°×µ°°×(HSA)ÊÔ¼ÁºÐ Ѫ˨ǰÌåµ°°×(TpP)ÊÔ¼ÁºÐѪºìµ°°×H(HbH)ÊÔ¼ÁºÐ Ѫºìµ°°×C

¹©Ó¦Àû¼ØÄòëÄ(KP) 2008Äê12ÔÂ31ÈÕ
Àû¼ØÄòëÄ(KP) Á£Ï¸°û¾ÞÊÉϸ°û¼¯Âä´Ì¼¤Òò×Ó(GM-CSF) Á£Ï¸°û¿Ë¡´Ì¼¤Òò×Ó(G-CSF) Á×֬øA2(PL-A2) ÁܰÍϸ°ûÇ÷»¯Òò×Ó(Lptn) ÁܰÍϸ°ûÒò×ÓÐźÅתµ¼·Ö×Ó(Smad1)

¹©Ó¦ÈéËáÍÑÇâø(LDH) 2008Äê12ÔÂ31ÈÕ
ÈéËáÍÑÇâø(LDH) É«ËØÉÏÆ¤ÑÜÉúÒò×Ó(PEDF) Éú³¤µ÷½ÚÖ°©»ùÒò1(GRO-1) ËèÇʼîÐÔµ°°×¿¹Ìå(anti-MBPAb) ͸Ã÷ÖÊËá½áºÏµ°°×(HABP) 賦°©±êÖ¾ÎïCA199 θµ°°×ø(P

¹©Ó¦ÒȸßѪÌÇËØ(GC)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÐÍÄÆÄòëÄ(CNP)ÊÔ¼ÁºÐ ѪÇå×ܲ¹Ìå»îÐÔ(CH50)ÊÔ¼ÁºÐ ÒÈÒÖÖÆËØ(Pancreastatin)ÊÔ¼ÁºÐ Òȼ¤ëÄԭø(PK)ÊÔ¼ÁºÐ ÒȸßѪÌÇËØ(GC)ÊÔ¼ÁºÐ ÒȶàëÄ(PP)ÊÔ¼ÁºÐ ÒȵºËØ×Ô

¹©Ó¦Ö÷Òª×éÖ¯ÏàÈÝÐÔ¸´ºÏÌå(MHC/HLA)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ö÷Òª×éÖ¯ÏàÈÝÐÔ¸´ºÏÌå(MHC/HLA)ÊÔ¼ÁºÐ Ö÷Òª×éÖ¯ÏàÈÝÐÔ¸´ºÏÌå-¢òÀà(MHC-¢ò)ÊÔ¼ÁºÐ Ö÷Òª×éÖ¯ÏàÈÝÐÔ¸´ºÏÌå-¢ñÀà(MHC-¢ñ)ÊÔ¼ÁºÐ ×éÖ¯µ°°×È¥ÒÒõ£»¯Ã¸(HDAC/HD)ÊÔ¼Á

¹©Ó¦¦Â2 Ìǵ°°×(¦Â2-GP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¦Â2 Ìǵ°°×(¦Â2-GP)ÊÔ¼ÁºÐ ¦ÃëÄ(P¦Ã)ÊÔ¼ÁºÐ ÌÇȱʧÐÔתÌúµ°°×(CDT)ÊÔ¼ÁºÐ ÌÇ»¯Ñªºìµ°°×/ÌÇÄò²¡ÌÇ»¯Ñªºìµ°°×(GHB)ÊÔ¼ÁºÐ ÌÇ»¯µ°°×(GSP)ÊÔ¼ÁºÐ ÌÇ»¯°×µ°°×(GA

¹©Ó¦´Ù˯ÃßëÄ(DSIP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
´Ù˯ÃßëÄ(DSIP)ÊÔ¼ÁºÐ ´¹ÌåÏÙÜÕËá»·»¯Ã¸¼¤»îëÄ(PACAP)ÊÔ¼ÁºÐ µ°°×C(Protein C)ÊÔ¼ÁºÐ LcK µ°°×(P56/LcK)ÊÔ¼ÁºÐ Fyn µ°°×(P59/Fyn)ÊÔ¼ÁºÐ µ°°×Á×Ëáø(PP)ÊÔ

¹©Ó¦ÒìÄûÃÊËáÍÑÇâø(ICD)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÒìÄûÃÊËáÍÑÇâø(ICD)ÊÔ¼ÁºÐ ÓÕµ¼ÐÍÒ»Ñõ»¯µªºÏ³Éø(iNOS)ÊÔ¼ÁºÐ Ò»Ñõ»¯µªºÏ³Éø(NOS)ÊÔ¼ÁºÐ ÒÖÖÆËØB(INH-B)ÊÔ¼ÁºÐ ¶¾Þ¦¼îÐÍÒÒõ£µ¨¼î(M-ACh)ÊÔ¼ÁºÐ Ò¶Ëá(FA)Ê

¹©Ó¦Ò»Ñõ»¯µªºÏ³Éø(NOS)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ò»Ñõ»¯µªºÏ³Éø(NOS)ÊÔ¼ÁºÐ ÒÖÖÆËØB(INH-B)ÊÔ¼ÁºÐ ¶¾Þ¦¼îÐÍÒÒõ£µ¨¼î(M-ACh)ÊÔ¼ÁºÐ Ò¶Ëá(FA)ÊÔ¼ÁºÐ Ñ̼îÐÍÒÒõ£µ¨¼î(N-ACh)ÊÔ¼ÁºÐ ÓÄÃÅÂÝÐý¸Ë¾úIgM(Hp-IgM)ÊÔ

¹©Ó¦µ¨¹Ì´¼õ¥×ªÒƵ°°×(CETP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
µ¨¹Ì´¼õ¥×ªÒƵ°°×(CETP)ÊÔ¼ÁºÐ D ¶þ¾ÛÌå(D2D)ÊÔ¼ÁºÐ »î»¯ÄýѪÒò×Ó¢ü(F¢üa)ÊÔ¼ÁºÐ ¿¹ÄýѪø¢ó¿¹Ìå(AT-¢ó)ÊÔ¼ÁºÐ ¿ÉÈÜÐÔѪС°åÄÚÆ¤Ï¸°ûÕ³¸½·Ö×Ó1(sPECAM-1)ÊÔ¼

¹©Ó¦ÄýѪÒò×Ó¢ù(F¢ù)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÄýѪÒò×Ó¢ù(F¢ù)ÊÔ¼ÁºÐ ÄýѪÒò×Ó¢ú(F¢ú)ÊÔ¼ÁºÐ ÄýѪÒò×Ó¢ò(F¢ò)ÊÔ¼ÁºÐ 11È¥ÇâѪ˨ÍéB2(11-DH-TXB2)ÊÔ¼ÁºÐ CC Ç÷»¯Òò×ÓÅäÌå5(CCL5)ÊÔ¼ÁºÐ ÈÜѪ²¹Ìå(Hc)ÊÔ¼Áº

¹©Ó¦Î¸ÒÖËØ(GIP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
θÒÖËØ(GIP)ÊÔ¼ÁºÐ ÐØÏÙÎåëÄ(TP-5)ÊÔ¼ÁºÐ ÐØÏÙëÄ(Thymosin)ÊÔ¼ÁºÐ ÐØÏÙ±í´ïµÄÇ÷»¯Òò×Ó(TECK)ÊÔ¼ÁºÐ ÐÍÄÆÄòëÄ(CNP)ÊÔ¼ÁºÐ ѪÇå×ܲ¹Ìå»îÐÔ(CH50)ÊÔ¼ÁºÐ ÒÈÒÖ

¹©Ó¦½µ¸ÆËØ(CT)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
½µ¸ÆËØ(CT)ÊÔ¼ÁºÐ ½µ¸ÆËØÔ­(PCT)ÊÔ¼ÁºÐ ½µ¸ÆËØ»ùÒòÏà¹ØëÄ(CGRP)ÊÔ¼ÁºÐ ¿¹Èí¹Ç¿¹Ìå(anti-cartilage-Ab)ÊÔ¼ÁºÐ ¿¹¾ÆÊ¯ËáËáÐÔÁ×Ëáø5b(TRACP-5b)ÊÔ¼ÁºÐ ¿ÉÈÜÐ

¹©Ó¦¼¡¸Æµ°°×¢ñ(Tn-¢ñ)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼¡¸Æµ°°×¢ñ(Tn-¢ñ)ÊÔ¼ÁºÐ ¼¡Ëἤøͬ¹¤Ã¸MB(CK-MB)ÊÔ¼ÁºÐ ¿¹Á×Ö¬¿¹Ìå(Apl/APA)ÊÔ¼ÁºÐ ¿¹ÐÄÁ×Ö¬¿¹Ìå(aCL/ACA)ÊÔ¼ÁºÐ ¿¹ÄýѪøÊÜÌå(ATR)ÊÔ¼ÁºÐ ÀÇ´¯¿¹Äý¿¹Ìå(

¹©Ó¦¿ÉÌáÈ¡ºË¿¹Ô­(ENA) 2008Äê12ÔÂ31ÈÕ
¿ÉÌáÈ¡ºË¿¹Ô­(ENA) ¿ÉÈÜÐÔ°×ϸ°û·Ö»¯¿¹Ô­21(sCD21) ¿ÉÈÜÐÔ°×ϸ°û·Ö»¯¿¹Ô­31(sCD31) ¿ÉÈÜÐÔ°×ϸ°û·Ö»¯¿¹Ô­38(sCD38) ¿ÉÈÜÐÔ°×ϸ°û·Ö»¯¿¹Ô­86(sCD86) ¿ÉÈÜÐÔÑ

¹©Ó¦Òȵ°°×øԭ¼¤»îëÄ(TAP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Òȵ°°×øԭ¼¤»îëÄ(TAP)ÊÔ¼ÁºÐ ÒȵºÏ¸°û¿¹Ìå(ICA)ÊÔ¼ÁºÐ ÒȵºËØÔ­(PI)ÊÔ¼ÁºÐ ÒȵíËØ(Amylin)ÊÔ¼ÁºÐ ÓÄÃÅÂÝÐý¾úIgG(Hp-IgG)ÊÔ¼ÁºÐ2(VEGFR-2/sFLK-1)ÊÔ¼ÁºÐ ×é

¹©Ó¦Ç×»·µ°°×/Ç×»·ËØA(CyPA)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ç×»·µ°°×/Ç×»·ËØA(CyPA)ÊÔ¼ÁºÐ ÈéÌú´«µÝµ°°×/ÈéÌúµ°°×¿¹ÌåIgG(LF/LTF Ab-Ig)ÊÔ¼ÁºÐ ÈÈÐݿ˵°°×60(Hsp-60)ÊÔ¼ÁºÐ ÉöÉÏÏÙÆ¤ÖÊ¿¹Ìå(ACA)ÊÔ¼ÁºÐ Ëè¹ýÑõ»¯Îïø(MP

¹©Ó¦»¨ÉúËÄÏ©Ëá(AA)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¹ÂëèëÄ(OFQ/N)ÊÔ¼ÁºÐ ¹ýÑõ»¯Ö¬ÖÊ/Èé¹ýÑõ»¯Îïø(LPO)ÊÔ¼ÁºÐ ¹ýÃô¶¾ËØC3a ¹ýÃô¶¾ËØC4a. ¹ýÃô¶¾ËØC5a. ºËÌǺËËáø(RNase)ÊÔ¼ÁºÐ ºËÒò×Ó¦ÊB ÊÜÌå»î»¯Òò×ÓÅä»ù

¹©Ó¦ÎìÌÇËØ(Pentosidine)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÎìÌÇËØ(Pentosidine)ÊÔ¼ÁºÐ ÐÂÉú¼××´ÏÙËØ(NN-T4)ÊÔ¼ÁºÐ ÐÔ¼¤ËؽáºÏÇòµ°°×(SHBG)ÊÔ¼ÁºÐ ÐÛ¼¤ËØÊÜÌå(AR)ÊÔ¼ÁºÐ ÐÛçÞÏ©¶þͪ(AD)ÊÔ¼ÁºÐ ÐÛÏ©¶þͪ(ASD)ÊÔ¼ÁºÐ

¹©Ó¦ÐÔ¼¤ËؽáºÏÇòµ°°×(SHBG)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÐÔ¼¤ËؽáºÏÇòµ°°×(SHBG)ÊÔ¼ÁºÐ ÐÛ¼¤ËØÊÜÌå(AR)ÊÔ¼ÁºÐ ÐÛçÞÏ©¶þͪ(AD)ÊÔ¼ÁºÐ ÐÛÏ©¶þͪ(ASD)ÊÔ¼ÁºÐ Ѫ¹Ü½ôÕÅËØÔ­(aGT)ÊÔ¼ÁºÐ Ѫ¹Ü½ôÕÅËØ¢ñ(Ang-¢ñ)ÊÔ¼ÁºÐ Ñ

¹©Ó¦µ°N¶ËǰÄÔÄÆËØ(NT-proBNP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
µ°°×Ö¬Öʵ°°×¿¹Ìå(PLP)ÊÔ¼ÁºÐ N¶ËǰÄÔÄÆËØ(NT-proBNP)ÊÔ¼ÁºÐ ´óÄÚÆ¤ËØ(Big ET)ÊÔ¼ÁºÐ ¼¡ºìµ°°×(MYO/MB)ÊÔ¼ÁºÐ ¼¡¸Æµ°°×¢ñ(Tn-¢ñ)ÊÔ¼ÁºÐ ¼¡Ëἤøͬ¹¤Ã¸MB(C

¹©Ó¦¸ßÃôÈýµâ¼××´ÏÙÔ­°±Ëá(u-T3)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¸ßÃôÈýµâ¼××´ÏÙÔ­°±Ëá(u-T3)ÊÔ¼ÁºÐ »ÆÌåÉú³ÉËØÊÍ·ÅÒò×Ó(LHRF)ÊÔ¼ÁºÐ »ÆÌåÉú³ÉËØÊͷż¤ËØ(LHRH)ÊÔ¼ÁºÐ ¼××´ÅÔÏÙ¼¤ËØÏà¹Øµ°°×(PTHrP)ÊÔ¼ÁºÐ ¼××´ÏÙËØ(T4)ÊÔ¼Áº

¹©Ó¦¿¹Ðļ¡¿¹ÌåIgM(AMA-IgM)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹Ðļ¡¿¹ÌåIgM(AMA-IgM)ÊÔ¼ÁºÐ ¿¹Ðļ¡¿¹ÌåIgG(AMA-IgG)ÊÔ¼ÁºÐ ¿¹Ðļ¡¿¹Ìå(AMA)ÊÔ¼ÁºÐ ¿¹ÏßÁ£Ì忹Ìå(AMA)ÊÔ¼ÁºÐ ¿¹Ó²Æ¤²¡¿¹Ìå70(anti-SCL70)ÊÔ¼ÁºÐ ¿¹ÒÈø¿¹

¹©Ó¦P16 »ùÒò(P16) 2008Äê12ÔÂ31ÈÕ
P16 »ùÒò(P16) ¿ÉÈÜÐÔѪ¹ÜÄÚÆ¤Ï¸°ûµ°°×C ÊÜÌå(sEPCR) ¿ÉÈÜÐÔÖ×Áö»µËÀÒò×Ó¦ÁÊÜÌå(sTNF¦ÁR) ¿ÉÈÜÐÔÖ×Áö»µËÀÒò×ÓÏà¹ØµòÍöÓÕµ¼ÅäÌå(sTRAIL) ¿¹Ö×Áö¶àëÄ(PA53) À

¹©Ó¦ÌÇ»¯Ñªºìµ°°×A1c(HbA1c)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÌÇ»¯Ñªºìµ°°×A1c(HbA1c)ÊÔ¼ÁºÐ ÌÇÁ´¿¹Ô­19-9(CA19-9)ÊÔ¼ÁºÐ ÌìÃŶ¬°±Ëá°±»ù×ªÒÆÃ¸(AST)ÊÔ¼ÁºÐ ͸Ã÷ÖÊËáø(HAase)ÊÔ¼ÁºÐ Í»´¥ËØ(SYN)ÊÔ¼ÁºÐ ÍÙÒºËá(SA)ÊÔ¼Á

¹©Ó¦ÁòËáÍʺÚÉ«ËØ(MS)ÊÔ¼ÁºÐ(1,5-AG)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÁòËáÍʺÚÉ«ËØ(MS)ÊÔ¼ÁºÐ(1,5-AG)ÊÔ¼ÁºÐ ÁòËáÀà¸ÎËØ(HS)ÊÔ¼ÁºÐ ÁܰÍϸ°û¹¦ÄÜÏà¹Ø¿¹Ô­3(LFA-3)ÊÔ¼ÁºÐ Á×ËáÆÏÌÑÌDZäλø(PGM)ÊÔ¼ÁºÐ ÁÁ°±õ£°±»ùëÄø(LAP)ÊÔ¼ÁºÐ

¹©Ó¦ÁÁ°±õ£°±»ùëÄø(LAP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÁÁ°±õ£°±»ùëÄø(LAP)ÊÔ¼ÁºÐ Á´¼¤Ã¸(SK)ÊÔ¼ÁºÐ ÀÒ°±ËáôÇ»¯Ã¸(TH)ÊÔ¼ÁºÐ ëϸѪ¹ÜÀ©ÕÅÐÔ¹²¼Ãʧµ÷Í»±ä»ùÒò(ATM)ÊÔ¼ÁºÐ ÃâÒßÇòµ°°×ÇáÁ´lambda(¦Ë-IgLC)ÊÔ¼ÁºÐ Ä

¹©Ó¦Ðļ¡×ªÂ¼Òò×ÓGATA4 2008Äê12ÔÂ31ÈÕ
Ðļ¡×ªÂ¼Òò×ÓGATA4 ÐØÏÙ»ùÖÊÁܰÍϸ°ûÉú³ÉËØ(TSLP) E Ñ¡ÔñËØ(E-Selectin) L Ñ¡ÔñËØ(L-Selectin) P Ñ¡ÔñËØ(P-Selectin) ѪÇåËØ/ѪÇå°·(ST) Ѫ¹ÜÉú³ÉËØ2(ANG-

¹©Ó¦ÍâÏÔëÄ(extein)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÍâÏÔëÄ(extein)ÊÔ¼ÁºÐ ϸ°û½Çµ°°×20(CK-20)ÊÔ¼ÁºÐ ϸ°û½Çµ°°×19(CK-19)ÊÔ¼ÁºÐ ϸ°û½Çµ°°×18(CK-18)ÊÔ¼ÁºÐ ϸ°û¿¹Ô­ÊÜÌå(TCR)ÊÔ¼ÁºÐ ϸ°ûÍâÐźŵ÷½Ú¼¤Ã¸(ERK

¹©Ó¦P ÎïÖÊ(SP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
P ÎïÖÊ(SP)ÊÔ¼ÁºÐ ÍâÏÔëÄ(extein)ÊÔ¼ÁºÐ ϸ°û½Çµ°°×20(CK-20)ÊÔ¼ÁºÐ ϸ°û½Çµ°°×19(CK-19)ÊÔ¼ÁºÐ ϸ°û½Çµ°°×18(CK-18)ÊÔ¼ÁºÐ ϸ°û¿¹Ô­ÊÜÌå(TCR)ÊÔ¼ÁºÐ ϸ°û

¹©Ó¦³¬Ñõ»¯ÎïÆç»¯Ã¸(SOD) 2008Äê12ÔÂ31ÈÕ
³¬Ñõ»¯ÎïÆç»¯Ã¸(SOD) ´ÙµòÍöµ°°×Bid ´¹²Ý±âÌÒËá(VMA) µ°°×¼¤Ã¸B(PKB) µ°°×¼¤Ã¸C(PKC) µÍÑõÓÕµ¼Òò×Ó1¦Á(HIF-1¦Á) ¶àëÄ(CP) ·ÇСϸ°û·Î°©¿¹Ô­(LTA) ·Î°©±ê

¹©Ó¦ÀàÊÈT ÁܰÍϸ°û¢ñÐͲ¡¶¾(HTLV-¢ñ)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÀàÊÈT ÁܰÍϸ°û¢ñÐͲ¡¶¾(HTLV-¢ñ)ÊÔ¼ÁºÐ ÀûʲÂüÔ­³æ¿¹Ìå(Leishimaria Ab)ÊÔ¼ÁºÐ Á¡¼²ÄÚ°¢Ã×°Í¿¹Ô­ Á÷¸Ð²¡¶¾¿¹ÌåIgG(FLU)ÊÔ¼ÁºÐ Á÷ÐÐÐÔÈùÏÙÑ×(EP)ÊÔ¼ÁºÐ ÂÖ×

¹©Ó¦½Þ×´Éñ¾­ÓªÑøÒò×Ó(CNTF) 2008Äê12ÔÂ31ÈÕ
½Þ×´Éñ¾­ÓªÑøÒò×Ó(CNTF) ½áµÞ×éÖ¯Éú³¤Òò×Ó(CTGF) ¾ÞÊÉϸ°ûÌæ´ú¼¤»îÏà¹Ø»¯Ñ§Òò×Ó1(AmAC-1) ¾ÞÊÉϸ°ûÒÆ¶¯ÒÖÖÆÒò×Ó(MIF) ¾ÞÊÉϸ°ûÑ×ÐÔµ°°×5(MIP-5) ¾ÞÊÉϸ°ûÑ×

¹©Ó¦°ûÉú³¤Òò×Ó(KGF) 2008Äê12ÔÂ31ÈÕ
°ûÉú³¤Òò×Ó(KGF) ½Ç»¯Ï¸°ûÄÚ·ÖÃÚÒò×Ó(KAF)/Ë«µ÷µ°°×(AR) ½ºÖÊϸ°ûϵÀ´Ô´µÄÉñ¾­ÓªÑøÒò×Ó(GDNF) ½Þ×´Éñ¾­ÓªÑøÒò×Ó(CNTF) ½áµÞ×éÖ¯Éú³¤Òò×Ó(CTGF) ¾ÞÊÉϸ°ûÌæ´

¹©Ó¦Òȵ°°×øԭ¢ò(Try-¢ò)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Òȵ°°×øԭ¢ò(Try-¢ò)ÊÔ¼ÁºÐ Òȵ°°×ø(trypsin)ÊÔ¼ÁºÐ ÒȵºËØÊÜÌå¦Â(ISR-¦Â)ÊÔ¼ÁºÐ ÒÒõ£µ¨¼îõ¥Ã¸(ChE)ÊÔ¼ÁºÐ N-ÒÒõ£-¦Â-D-°±»ùÆÏÌÑÌÇÜÕø(NAG)ÊÔ¼ÁºÐ ÒÒõ£µ

¹©Ó¦ÒȵºËØÊÜÌå¦Â(ISR-¦Â)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÒȵºËØÊÜÌå¦Â(ISR-¦Â)ÊÔ¼ÁºÐ ÒÒõ£µ¨¼îõ¥Ã¸(ChE)ÊÔ¼ÁºÐ N-ÒÒõ£-¦Â-D-°±»ùÆÏÌÑÌÇÜÕø(NAG)ÊÔ¼ÁºÐ ÒÒõ£µ¨¼î(ACH)ÊÔ¼ÁºÐ ÒÒ°·µâ߻ͪ(AD)ÊÔ¼ÁºÐ ÓÎÀëÔ­ß²ßø(FEP)

¹©Ó¦8 ÒìǰÁÐÏÙËØF2¦Á(8-iso-PG-F2¦Á)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
8 ÒìǰÁÐÏÙËØF2¦Á(8-iso-PG-F2¦Á)ÊÔ¼ÁºÐ ÒÒõ£µ¨¼îÊÜÌ忹Ìå(AChRab)ÊÔ¼ÁºÐ ÓÎÀë¼××´ÏÙËØ(FT4)ÊÔ¼ÁºÐ ÓÎÀëÈýµâ¼××´ÏÙÔ­°±Ëá(Free-T3)ÊÔ¼ÁºÐ ÓÎÀëØºÍª(F-TESTO)

¹©Ó¦¿¹ÑÛ¼¡¿¹Ìå(EMAb)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹ÑÛ¼¡¿¹Ìå(EMAb)ÊÔ¼ÁºÐ ¿¹Ô­´¦ÀíÏà¹Ø×ªÔ˵°°×(TAP)ÊÔ¼ÁºÐ ¿¹ÔØÖ¬µ°°×¿¹ÌåA1(Apo A1)ÊÔ¼ÁºÐ ¿¹×éµ°°×¿¹Ìå(AHA)ÊÔ¼ÁºÐ ¿¹IgA ¿¹Ìå(anti-IgA-Ab)ÊÔ¼ÁºÐ ¦Á1 ¿

¹©Ó¦¿¹ÍøÓ²µ°°×¿¹Ìå(ARA)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹ÍøÓ²µ°°×¿¹Ìå(ARA)ÊÔ¼ÁºÐ ¿¹ÑÛ¼¡¿¹Ìå(EMAb)ÊÔ¼ÁºÐ ¿¹Ô­´¦ÀíÏà¹Ø×ªÔ˵°°×(TAP)ÊÔ¼ÁºÐ ¿¹ÔØÖ¬µ°°×¿¹ÌåA1(Apo A1)ÊÔ¼ÁºÐ ¿¹×éµ°°×¿¹Ìå(AHA)ÊÔ¼ÁºÐ ¿¹IgA ¿¹Ì

¹©Ó¦ÐØÏÙ±í´ïµÄÇ÷»¯Òò×Ó(TECK)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÐØÏÙ±í´ïµÄÇ÷»¯Òò×Ó(TECK)ÊÔ¼ÁºÐ ÐÍÄÆÄòëÄ(CNP)ÊÔ¼ÁºÐ ѪÇå×ܲ¹Ìå»îÐÔ(CH50)ÊÔ¼ÁºÐ ÒÈÒÖÖÆËØ(Pancreastatin)ÊÔ¼ÁºÐ Òȼ¤ëÄԭø(PK)ÊÔ¼ÁºÐ ÒȸßѪÌÇËØ(GC)ÊÔ

¹©Ó¦´ÙÐÔÏÙ¼¤ËØÊͷż¤ËØ(GnRH)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
´ÙÉöÉÏÏÙÆ¤Öʼ¤ËØ(ACTH)ÊÔ¼ÁºÐ ´ÙÉöÉÏÆ¤Öʼ¤ËØÊͷż¤ËØ(CRH)ÊÔ¼ÁºÐ ´ÙÐÔÏÙ¼¤ËØÊͷż¤ËØ(GnRH)ÊÔ¼ÁºÐ ´ÙÂÑÅÝËØ(FSH)ÊÔ¼ÁºÐ ´ßÈéËØ(PRL)ÊÔ¼ÁºÐ µÖ¿¹ËØ(Resist

¹©Ó¦Ç¿·ÈëÄ(Dyn)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ôÇ»ù½ºÔ­ßÁऽ»Áª(OH-PYD)ÊÔ¼ÁºÐ Ç¿·ÈëÄ(Dyn)ÊÔ¼ÁºÐ ÇåµÀ·òÊÜÌå(SR)ÊÔ¼ÁºÐ È¥ÍÙÒºËáÌǵ°°×ÊÜÌå(ASGPR)ÊÔ¼ÁºÐ ȱѪÐÞÊΰ׵°°×(IMA)ÊÔ¼ÁºÐ ÈÈÐݿ˵°°×27(HSP

¹©Ó¦µþµªÐØÜÕ(AZT)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
µþµªÐØÜÕ(AZT)ÊÔ¼ÁºÐ ¶à°Í°·(DA)ÊÔ¼ÁºÐ ¸ßÃô¼××´ÏÙËØ(u-T4)ÊÔ¼ÁºÐ ¶þëÄ»ùëÄø¢ô(DPP¢ô)ÊÔ¼ÁºÐ ·ÖÃÚÐÍÃâÒßÇòµ°°×A(SIgA)ÊÔ¼ÁºÐ ¸ßÁéÃô¶È´Ù¼××´ÏÙ¼¤ËØ(U-TSH)

¹©Ó¦ÌìÇàÉ±ËØ(AZU)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÌìÇàÉ±ËØ(AZU)ÊÔ¼ÁºÐ ÍÑÑõ½ºÔ­ßÁऽ»Áª(DPD)ÊÔ¼ÁºÐ ÍíÆÚÑõ»¯µ°°×²úÎï(AOPP)ÊÔ¼ÁºÐ ÍøÓ²µ°°×(Reticulin)ÊÔ¼ÁºÐ θÃÚËØÊÍ·ÅëÄǰÌå(ProGRP)ÊÔ¼ÁºÐ θÃÚËØÊͷŶ

¹©Ó¦Í­À¶µ°°×(CP/CER)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Í­À¶µ°°×(CP/CER)ÊÔ¼ÁºÐ Ì¥¶ùѪºìµ°°×(HBF)ÊÔ¼ÁºÐ Ì×Ĥµ°°×(iNV)ÊÔ¼ÁºÐ ÌìÇàÉ±ËØ(AZU)ÊÔ¼ÁºÐ ÍÑÑõ½ºÔ­ßÁऽ»Áª(DPD)ÊÔ¼ÁºÐ ÍíÆÚÑõ»¯µ°°×²úÎï(AOPP)ÊÔ¼ÁºÐ

¹©Ó¦K ¿¹C1q ¿¹Ìå(C1q-Ab) 2008Äê12ÔÂ31ÈÕ
K ¿¹C1q ¿¹Ìå(C1q-Ab) ¿¹ºË¿¹Ìå(ANA) ¿¹ÀûÄò¼¤ËØ(ADH) Ѫ¹Ü¼ÓÑ¹ËØ£¨VP£©ÊÔ¼ÁºÐÊÔ¼ÁºÐÊÔ¼ÁºÐ ¾«°±Ëá¼ÓÑ¹ËØ£¨AVP£©ÊÔ¼ÁºÐÊÔ¼ÁºÐÊÔ¼ÁºÐ ¿¹¦Á¸ÉÈÅËØ¿¹Ìå(IFN¦Á-

¹©Ó¦Ðļ¡ÌØÒìÐÔ¼¡¸Æµ°°×T(cTnT)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ðļ¡ÌØÒìÐÔ¼¡¸Æµ°°×T(cTnT)ÊÔ¼ÁºÐ ÐÄÐÍÖ¬·¾Ëá½áºÏµ°°×(h-FABP)ÊÔ¼ÁºÐ ÏÙÜÕÈýÁ×Ëá½áºÏºÐתÔËÌåA1(ABCA1)ÊÔ¼ÁºÐ ѪÇå°×µ°°×(HSA)ÊÔ¼ÁºÐ Ѫ˨ǰÌåµ°°×(TpP)ÊÔ¼Á

¹©Ó¦¸ßÁéÃô¶È´Ù¼××´ÏÙ¼¤ËØ(U-TSH)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¸ßÁéÃô¶È´Ù¼××´ÏÙ¼¤ËØ(U-TSH)ÊÔ¼ÁºÐ ¹È°±ËáÍÑôÈø×ÔÉí¿¹Ìå(GAD-Ab)ÊÔ¼ÁºÐ ¼×ë¿Ç°ÁÐÏÙËØD2(PGD2-MOX)ÊÔ¼ÁºÐ ¼××´Ïٴ̼¤¼¤ËØ(TSI)ÊÔ¼ÁºÐ ¼××´ÅÔÏÙ¼¤ËØ(PTH)ÊÔ¼

¹©Ó¦¹ÂëèëÄ(OFQ/N)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¹ÂëèëÄ(OFQ/N)ÊÔ¼ÁºÐ ¹ýÑõ»¯Ö¬ÖÊ/Èé¹ýÑõ»¯Îïø(LPO)ÊÔ¼ÁºÐ ¹ýÃô¶¾ËØC3a ¹ýÃô¶¾ËØC4a. ¹ýÃô¶¾ËØC5a. ºËÌǺËËáø(RNase)ÊÔ¼ÁºÐ ºËÒò×Ó¦ÊB ÊÜÌå»î»¯Òò×ÓÅä»ù

¹©Ó¦È©Ëõø(ALD) 2008Äê12ÔÂ31ÈÕ
È©Ëõø(ALD) ÈÈÐݿ˵°°×Ìǵ°°×96(HSP gp96) ÈÈÐݿ˵°°×90(HSP-90) ÈÈÐݿ˵°°×70(HSP-70) ÈÈÐݿ˵°°×40(HSP-40) ÈÈÐݿ˵°°×20(HSP-20) ÈéÏÙ°©±êÖ¾Îï-CA153

¹©Ó¦ÃâÒßÇòµ°°×ÇáÁ´lambda(¦Ë-IgLC)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÃâÒßÇòµ°°×ÇáÁ´lambda(¦Ë-IgLC)ÊÔ¼ÁºÐ Äñ°±Ëá°±»ù¼×õ£×ªÒÆÃ¸(OCT)ÊÔ¼ÁºÐ Äñ°±ËáÍÑôÈø(ODC)ÊÔ¼ÁºÐ Äò¼¤Ã¸(UK)ÊÔ¼ÁºÐ ÓÎÀëÆ¤ÖÊ´¼(UFC)ÊÔ¼ÁºÐ ¦ÂÝÁ·Ó(¦Â-nap

¹©Ó¦ÂÝÐýëÄ(Helical Peptide)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÂÝÐýëÄ(Helical Peptide)ÊÔ¼ÁºÐ Âó½Çµ°°×IgA(Gliadin-IgA)ÊÔ¼ÁºÐ ÃÀÖÞÉÌÂ½ËØ(PWM)ÊÔ¼ÁºÐ ÃâÒßÇòµ°°×Ñùת¼ÌåÊÜÌå(ILTsR)ÊÔ¼ÁºÐ ÃâÒßÒÖÖÆËáÐÔµ°°×(IAP)ÊÔ¼ÁºÐ

¹©Ó¦»ùÖʦÃôÈ»ù¹È°±Ëáµ°°×(MGP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
»ùÖʦÃôÈ»ù¹È°±Ëáµ°°×(MGP)ÊÔ¼ÁºÐ »ùÖÊÁѽ⵰°×(MAT)ÊÔ¼ÁºÐ ¼××´ÏÙ½áºÏÇòµ°°×(TBG)ÊÔ¼ÁºÐ ½ºÔ­ßÁऽ»Áª(PYD)ÊÔ¼ÁºÐ ½ºÔ­µ°°×(CL)ÊÔ¼ÁºÐ ½ºÔ­µ°°×¢ò(HCB¢ò)Ê

¹©Ó¦ÃâÒßÇòµ°°×A(IgA) 2008Äê12ÔÂ31ÈÕ
ÃâÒßÇòµ°°×A(IgA) ÃâÒßÇòµ°°×G(IgG) ÃâÒßÇòµ°°×M(IgM) ÃçÌõËØÊÜÌå(LR/Ob-R) ÄÔ³¦ëÄ(BGP/Gehrelin) ÄÔÄÆËØ/ÄÔÄÆÄòëÄ(BNP) ÄÔÔ´ÐÔÉñ¾­ÓªÑøÒò×Ó(BDNF) ÄÚÒò×

¹©Ó¦¼ºÌǼ¤Ã¸(HK)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼ºÌǼ¤Ã¸(HK)ÊÔ¼ÁºÐ ½áµ°°×(Des)ÊÔ¼ÁºÐ ½áºÏÖéµ°°×/´¥Öéµ°°×(Hpt/HP)ÊÔ¼ÁºÐ ¿¹¸ÎÌØÒìÐÔÖ¬µ°°×¿¹Ìå(LSP)ÊÔ¼ÁºÐ ¿¹»·¹Ï°±ËáëÄ¿¹Ìå(CCP)ÊÔ¼ÁºÐ ¿¹½Çµ°°×Ë¿¾Û¼¯

¹©Ó¦¼×»ù»¯Ã¸(Methylase)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼×»ù»¯Ã¸(Methylase)ÊÔ¼ÁºÐ

¹©Ó¦¼××´ÏÙ¹ýÑõ»¯Îïø(TPO)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼××´ÏÙ¹ýÑõ»¯Îïø(TPO)ÊÔ¼ÁºÐ

¹©Ó¦¦Â-´ÙÖ¬ËØ(¦Â-LPH)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¦Â-´ÙÖ¬ËØ(¦Â-LPH)ÊÔ¼ÁºÐ µ°°×¶þÁò»¯ÎïÒ칹øA3(PDIA3)ÊÔ¼ÁºÐ µ°°×¶þÁò»¯ÎïÒ칹øǰÌå(PDI)ÊÔ¼ÁºÐ µ°°×ÖʶþÁò¼üÒ칹ø(PDI)ÊÔ¼ÁºÐ µ°°×ø3 ¿¹Ìå(PR3Ab)ÊÔ¼Áº

¹©Ó¦³¬¿¹Ô­(Sag)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
³¬¿¹Ô­(Sag)ÊÔ¼ÁºÐ ´ÙÎ¸ÒºËØÊÜÌå(GsaR)ÊÔ¼ÁºÐ ¦Â-´ÙÖ¬ËØ(¦Â-LPH)ÊÔ¼ÁºÐ µ°°×¶þÁò»¯ÎïÒ칹øA3(PDIA3)ÊÔ¼ÁºÐ µ°°×¶þÁò»¯ÎïÒ칹øǰÌå(PDI)ÊÔ¼ÁºÐ µ°°×ÖʶþÁò

¹©Ó¦»ùÖʽðÊôµ°°×ø1(MMP-1)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
»ùÖʽðÊôµ°°×ø1(MMP-1)ÊÔ¼ÁºÐ »ùÖʽðÊôµ°°×ø2/Ã÷½ºÃ¸A(MMP-2/Gelatinase A)ÊÔ¼ÁºÐ »ùÖʽðÊôµ°°×ø3(MMP-3)ÊÔ¼ÁºÐ »ùÖʽðÊôµ°°×ø4(MMP-4)ÊÔ¼ÁºÐ »ùÖʽðÊôµ

¹©Ó¦°éµ°°×(CPN)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
×ãϸ°û±ê¼Çµ°°×(PCX)ÊÔ¼ÁºÐ ×é°·(HIS)ÊÔ¼ÁºÐ ÈËÌØÖÖµ°°×ϵÁмì²âELISA ÊÔ¼ÁºÐ[Human Special Protein ELISA Kit] °¢À­²®°ëÈéÌǵ°°×(AGPs)ÊÔ¼ÁºÐ °×ϸ°ûµ

¹©Ó¦¶à°Í°·(DA)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
µþµªÐØÜÕ(AZT)ÊÔ¼ÁºÐ ¶à°Í°·(DA)ÊÔ¼ÁºÐ ¸ßÃô¼××´ÏÙËØ(u-T4)ÊÔ¼ÁºÐ ¶þëÄ»ùëÄø¢ô(DPP¢ô)ÊÔ¼ÁºÐ ·ÖÃÚÐÍÃâÒßÇòµ°°×A(SIgA)ÊÔ¼ÁºÐ ¸ßÁéÃô¶È´Ù¼××´ÏÙ¼¤ËØ(U-TSH)

¹©Ó¦ËáÐÔÁ×Ëáø(ACP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ËáÐÔÁ×Ëáø(ACP)ÊÔ¼ÁºÐ ËáÐÔÉñ¾­ÇÊÁ×֬ø(ASM)ÊÔ¼ÁºÐ ÉÏÆ¤ÌØÒìÐÔ¿¹Ô­(ESA)ÊÔ¼ÁºÐ ÉÏÆ¤Ä¤¿¹Ô­(EMA)ÊÔ¼ÁºÐ ÉÏÆ¤ÌØÒìÐÔ¿¹Ô­(ESA)ÊÔ¼ÁºÐ ÉÏÆ¤ÖÐÐÔÁ£Ï¸°û»î»¯ëÄ7

¹©Ó¦¼××´ÏÙ½áºÏÇòµ°°×(TBG)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¼××´ÏÙ½áºÏÇòµ°°×(TBG)ÊÔ¼ÁºÐ ½ºÔ­ßÁऽ»Áª(PYD)ÊÔ¼ÁºÐ ½ºÔ­µ°°×(CL)ÊÔ¼ÁºÐ ½ºÔ­µ°°×¢ò(HCB¢ò)ÊÔ¼ÁºÐ ½ºÔ­Äý¼¯ËØ(Collectin)ÊÔ¼ÁºÐ ¾Û¼¯µ°°×(Agrin)ÊÔ¼ÁºÐ

¹©Ó¦ÆÏÌÑÌǼ¤Ã¸µ÷½Úµ°°×(GKRP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÆÏÌÑÌǼ¤Ã¸µ÷½Úµ°°×(GKRP)ÊÔ¼ÁºÐ ǰ°×µ°°×(PA)ÊÔ¼ÁºÐ ÇÅÁ£Ð¾Ìǵ°°×-1(Dsg-1)ÊÔ¼ÁºÐ ôǸ¬°±ËáÌǵ°°×(HRGP)ÊÔ¼ÁºÐ ôÇ»ù½ºÔ­ßÁऽ»Áª(OH-PYD)ÊÔ¼ÁºÐ Ç¿·ÈëÄ(Dy

¹©Ó¦ÃâÒßÒÖÖÆËáÐÔµ°°×(IAP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÃâÒßÒÖÖÆËáÐÔµ°°×(IAP)ÊÔ¼ÁºÐ N ÄÔ·ÈëÄ(ENK)ÊÔ¼ÁºÐ Äòµ°°×(UP)ÊÔ¼ÁºÐ Äò΢Á¿°×µ°°×(ALB)ÊÔ¼ÁºÐ P ƽ»¬¼¡¼¡Çòµ°°×(SMM)ÊÔ¼ÁºÐ ¦Áƽ»¬¼¡¼¡¶¯µ°°×(¦Á-SMA)ÊÔ¼

¹©Ó¦ÀäÇòµ°°×(CG)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÀäÇòµ°°×(CG)ÊÔ¼ÁºÐ ¦ÂÁ¬»·µ°°×/Áªµ°°×(¦Â-Cat)ÊÔ¼ÁºÐ ÁòÑõ»¹µ°°×»¹Ô­Ã¸(TrxR)ÊÔ¼ÁºÐ ÁòÑõ»¯»¹Ô­µ°°×(Trx)ÊÔ¼ÁºÐ ÁòËá¸ÎËØÌǵ°°×(HSPG)ÊÔ¼ÁºÐ ÂÝÐýëÄ(Heli

¹©Ó¦¿¹¾ÞÊÉϸ°û¿¹Ìå(anti-macrophage Ab)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹¾ÞÊÉϸ°û¿¹Ìå(anti-macrophage Ab)ÊÔ¼ÁºÐ ¿¹Á×±ÚËΌÌå(TA)ÊÔ¼ÁºÐ ¿¹Á×Ö¬õ£Ë¿°±ËΌÌå(APSA)ÊÔ¼ÁºÐ ¿¹ÁܰÍϸ°û¿¹Ìå(ALA)ÊÔ¼ÁºÐ ¿¹Àà·çʪ¹Ø½ÚÑ׺˿¹Ô­¿¹Ìå(

¹©Ó¦ºìϸ°ûÉú³ÉËØ(EPO)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ºìϸ°ûÉú³ÉËØ(EPO)ÊÔ¼ÁºÐ ºìϸ°ûÉú³ÉËØÊÜÌå(EPOR)ÊÔ¼ÁºÐ

¹©Ó¦ºËת¼Òò×Ó-¦ÊB ÑÇ»ùp65 Ç׺ÍëÄ(NF-¦ÊB p65)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ºËת¼Òò×Ó-¦ÊB ÑÇ»ùp65 Ç׺ÍëÄ(NF-¦ÊB p65)ÊÔ¼ÁºÐ

¹©Ó¦È©¹Ìͪ(ALD)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
È©¹Ìͪ(ALD)ÊÔ¼ÁºÐ ÌÇÔ­ºÏ³Éø¼¤Ã¸(GSK)ÊÔ¼ÁºÐ ÍíÆÚÌÇ»ù»¯ÖÕÄ©²úÎï(AGEs)ÊÔ¼ÁºÐ ÍøÄ¤ËØ(omentin)ÊÔ¼ÁºÐ θÒÖËØ(GIP)ÊÔ¼ÁºÐ ÐØÏÙÎåëÄ(TP-5)ÊÔ¼ÁºÐ ÐØÏÙëÄ(

¹©Ó¦ÓÅÇòµ°°×(EL)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
ÓÅÇòµ°°×(EL)ÊÔ¼ÁºÐ Ó㾫µ°°×(Protamine)ÊÔ¼ÁºÐ Ö¬¶àÌǽáºÏµ°°×(LBP)ÊÔ¼ÁºÐ Ö¬·¾Ëá½áºÏµ°°×(FABP)ÊÔ¼ÁºÐ Ö¬·¾·Ö»¯Ïà¹Øµ°°×(ADRP)ÊÔ¼ÁºÐ ÖÐÐÔÁ£Ï¸°ûÃ÷½ºÃ¸Ïà

¹©Ó¦¿¹ÉöÉÏÏÙÆ¤ÖÊ¿¹Ìå(AAA)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹ÉöÉÏÏÙÆ¤ÖÊ¿¹Ìå(AAA)ÊÔ¼ÁºÐ ¿¹ÉöÉÏÏÙϸ°û¿¹Ìå(AAA)ÊÔ¼ÁºÐ ¿¹ÉöСÇò»ùµ×Ĥ¿¹ÌåIgE(GBM-Ab-IgE)ÊÔ¼ÁºÐ ¿¹Éñ¾­½ÚÜÕÖ¬¿¹Ìå(GM1)ÊÔ¼ÁºÐ ¿¹Éñ¾­Ä¸Ï¸°ûÁö¿¹Ìå(NB-

¹©Ó¦¿¹Éñ¾­Ä¸Ï¸°ûÁö¿¹Ìå(NB-Ab)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
¿¹Éñ¾­Ä¸Ï¸°ûÁö¿¹Ìå(NB-Ab)ÊÔ¼ÁºÐ ¿¹Éú³¤¼¤ËØ¿¹Ìå(GHAb)ÊÔ¼ÁºÐ ¿¹ÈùÏٹܿ¹Ìå(anti-parotid duct Ab)ÊÔ¼ÁºÐ ¿¹Ìǵ°°×¿¹Ìå(GP)ÊÔ¼ÁºÐ ¿¹Î¸±Úϸ°û¿¹Ìå(AGPA)ÊÔ¼

¹©Ó¦Ö¬¶àÌǽáºÏµ°°×(LBP)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
Ö¬¶àÌǽáºÏµ°°×(LBP)ÊÔ¼ÁºÐ Ö¬·¾Ëá½áºÏµ°°×(FABP)ÊÔ¼ÁºÐ Ö¬·¾·Ö»¯Ïà¹Øµ°°×(ADRP)ÊÔ¼ÁºÐ ÖÐÐÔÁ£Ï¸°ûÃ÷½ºÃ¸Ïà¹ØÖ¬ÖÊÔËÔØµ°°×(NGAL)ÊÔ¼ÁºÐ ×ÅË¿Á£µ°°×B(CENP-B)

¹©Ó¦»ÆÌåÉú³ÉËØÊÍ·ÅÒò×Ó(LHRF)ÊÔ¼ÁºÐ 2008Äê12ÔÂ31ÈÕ
»ÆÌåÉú³ÉËØÊÍ·ÅÒò×Ó(LHRF)ÊÔ¼ÁºÐ »ÆÌåÉú³ÉËØÊͷż¤ËØ(LHRH)ÊÔ¼ÁºÐ ¼××´ÅÔÏÙ¼¤ËØÏà¹Øµ°°×(PTHrP)ÊÔ¼ÁºÐ ¼××´ÏÙËØ(T4)ÊÔ¼ÁºÐ ¼××´ÏÙËØ¿¹Ìå(TAb)ÊÔ¼ÁºÐ ¼××´ÏÙ

  »Øµ½¶¥²¿

µ±Ç°µÚ47088Ò³ ¹²54516Ò³¡£µÚÒ»Ò³ ÉÏÒ»Ò³ ÏÂÒ»Ò³ ×îºóÒ»Ò³ 

¡¡

°Ë·½ÒµÎñ | ÔÚÏ߿ͷþ | Ãâ·Ñ×¢²á | ¹ã¸æ¼Æ»® | ÓÑÇéÁ´½Ó | ÍøÉÌѧԺ | °ïÖúÖÐÐÄ | »áÔ±µÇ¼ | °Ë·½±Ò
©2009 B2b168.com ²úÆ·¹Ø×¢°ñ International E-Commerce Holding (S.Z) Limited
¿Í»§·þÎñ£ºWebMaster@b2b168.com    ¼¼ÊõÖ§³Ö£º Support@b2b168.com
QQÈÈÏߣº6310393 | 772175223¡¡
°Ë·½Í¨Ö§³Ö£ºsupport | b2b168